A model to predict survival in patients with end-stage liver disease

Hepatology

Volumn 33, Issue 2, 2001, Pages 464-470

  Kamath, Patrick S ^a   Wiesner, Russell H ^a   Malinchoc, Michael ^a   Kremers, Walter ^a   Therneau, Terry M ^a   Kosberg, Catherine L ^a   D’amico, Gennaro ^b   Dickson, E Rolland ^a   Kim, W Ray ^a  

^a MAYO CLINIC   (United States)

^b VILLA SOFIA CERVELLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; FEMALE; HOSPITALIZATION; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; PORTOSYSTEMIC ANASTOMOSIS; PREDICTION; PRIORITY JOURNAL; PROTHROMBIN TIME; RELIABILITY; RESOURCE ALLOCATION; REVIEW; SURVIVAL RATE;

EID: 0035146422     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.22172     Document Type: Article

References (36)

1. Organ procurement and transplantation network - HRSA. Final rule with comment period
2. Analysis of waiting times
3. Liver transplant waiting time does not correlate with waiting list mortality: Implications for liver allocation policy
4. Minimal criteria for placement of adults on the liver transplant waiting list: A report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases
5. What do we mean by validating a prognostic model?
6. Assessing the generalizability of prognostic information
7. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts
8. Further report of a prospective randomized trial comparing distal splenorenal shunt with end-to-side portacaval shunt. An analysis of encephalopathy, survival, and quality of life
9. The meaning and use of the area under a receiver operating characteristic (ROC) curve
10. Precision and accuracy of the international normalized ratio for prothrombin time in oral anticoagulation control
11. Prognosis in primary biliary cirrhosis: Model for decision making
12. Extramural cross-validation of the Mayo primary biliary cirrhosis survival model establishes its generalizability
13. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis
14. Hepatic encephalopathy
15. The course of patients after variceal hemorrhage
16. Survival after a first episode of spontaneous bacterial peritonitis. Prognosis of potential candidates for orthotopic liver transplantation
17. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: A consensus document
18. Primary biliary cirrhosis
19. Primary sclerosing cholangitis
20. Medical progress-biliary tract cancers
21. Ursodiol for primary sclerosing cholangitis
22. Prediction of creatinine clearance from serum creatinine
23. Transection of the oesophagus for bleeding oesophageal varices
24. Surgery and portal hypertension
25. Prognostic value of Child-Turcotte criteria in medically treated cirrhosis
26. Prothrombin time in liver failure: Time, ratio, activity percentage, or international normalized ratio?
27. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites
28. Liver transplantation in patients with non-biliary cirrhosis: Prognostic value of preoperative factors
29. Impact of pretransplant renal function on survival after liver transplantation
30. Prognostic value of preoperatively obtained clinical and laboratory data in predicting survival following orthotopic liver transplantation
31. A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease
32. A model for prediction of in hospital mortality in cirrhotic patients with spontaneous bacterial peritonitis
33. Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients
34. Determinants of outcome of compensated hepatitis C virus-related cirrhosis
35. The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States
36. Hepatitis C virus related cirrhosis: Time to occurrence of hepatocellular carcinoma and death